Abstract:It has been reported that majority of cases of gigantomastia, also known as breast hypertrophy and macromastia, occur during either pregnancy or puberty. Gigantomastia is a rare disorder that does not have a clear etiology or well-established risk factors. We present a 26-year-old female patient who appeared to have pregnancy-associated gigantomastia recurrence, large accessory breast and, ectopic breast tissue at external genital three years after bilateral breast reduction surgery. The patient successively u… Show more
“…The probable associated risk factors are described. The disease occurs in multiparous according to some authors [2, 4, 9], rarely in nulliparous women [11]; in our case study and as reported by other authors [5, 8], it occurs in the second gravidity. White race more involved in the literature, is more an observation than just a rational explanation [12].…”
Section: Discussionsupporting
confidence: 86%
“…The last impose an immediate [7] or differed [11] reconstruction according to the local conditions. However, reductive surgery exposes to risk of recurrence in some rare cases that have been described [5]. We opted for this plastic surgery on a patient who rejected bilateral mastectomy despite counseling concerning the risk of recurrence even though she did not desire future pregnancy.…”
Section: Discussionmentioning
confidence: 99%
“…The authors are unanimous on the local care to be brought about the cutaneous ulceration and the inefficiency of the hormonal medical treatment [2, 3]. For this benign disease, the option between radical surgery with immediate reconstruction or differed reconstruction protecting against potential recurrence [7] and mammary reduction surgery exposed to recurrence is a scientific debate [2, 5].…”
Introduction. Gestational gigantomastia is a rare benign disease of unknown cause. We report a case of bilateral gigantomastia in pregnancy in order to locate the place of reductive surgery in its care which is quite controversial. Case. A 25-year-old woman gravida 2 para 1 was referred for an exaggerated bilateral breast enlargement at 32-week gestation. The examination showed bilateral giant breasts with collateral venous circulation and trophic changes marked by the necrosis of the distal third of the mammary skin involving the nipple-areolar complex. She underwent a biopsy of the ulcerative breast tissue, and the histology report did not show a malignant cell. After active foetal lung maturation and induced delivery, a breast reductive surgery with nipple plasty was performed 21 days postpartum. The postoperative course was marked by a period of lymphangitis. The cosmetic and psychological result was satisfactory at 6 months and at 18 months. Conclusion. Gestational gigantomastia is a benign disease that can simulate carcinomatous mastitis. The breast reductive plasty keeps its place in our context.
“…The probable associated risk factors are described. The disease occurs in multiparous according to some authors [2, 4, 9], rarely in nulliparous women [11]; in our case study and as reported by other authors [5, 8], it occurs in the second gravidity. White race more involved in the literature, is more an observation than just a rational explanation [12].…”
Section: Discussionsupporting
confidence: 86%
“…The last impose an immediate [7] or differed [11] reconstruction according to the local conditions. However, reductive surgery exposes to risk of recurrence in some rare cases that have been described [5]. We opted for this plastic surgery on a patient who rejected bilateral mastectomy despite counseling concerning the risk of recurrence even though she did not desire future pregnancy.…”
Section: Discussionmentioning
confidence: 99%
“…The authors are unanimous on the local care to be brought about the cutaneous ulceration and the inefficiency of the hormonal medical treatment [2, 3]. For this benign disease, the option between radical surgery with immediate reconstruction or differed reconstruction protecting against potential recurrence [7] and mammary reduction surgery exposed to recurrence is a scientific debate [2, 5].…”
Introduction. Gestational gigantomastia is a rare benign disease of unknown cause. We report a case of bilateral gigantomastia in pregnancy in order to locate the place of reductive surgery in its care which is quite controversial. Case. A 25-year-old woman gravida 2 para 1 was referred for an exaggerated bilateral breast enlargement at 32-week gestation. The examination showed bilateral giant breasts with collateral venous circulation and trophic changes marked by the necrosis of the distal third of the mammary skin involving the nipple-areolar complex. She underwent a biopsy of the ulcerative breast tissue, and the histology report did not show a malignant cell. After active foetal lung maturation and induced delivery, a breast reductive surgery with nipple plasty was performed 21 days postpartum. The postoperative course was marked by a period of lymphangitis. The cosmetic and psychological result was satisfactory at 6 months and at 18 months. Conclusion. Gestational gigantomastia is a benign disease that can simulate carcinomatous mastitis. The breast reductive plasty keeps its place in our context.
“…GG or gravida macromastia is defined as a disorder characterized by diffuse, extreme, and disabling enlargement of one or both breasts during pregnancy, which was first described in 1648 by Palmuth 1,2,6 . Its etiology is still unknown 1,7,8 .…”
Gestational gigantomastia (GG) is a disease defined by rapid and disproportionate breast enlargement in pregnancy. Its complications may lead to emergency mastectomy or induced miscarriage. We present a case report in which pregnancy had a favorable evolution after the surgical intervention of the breasts.
“…• Definition: Breast hyperplasia, presenting as large breasts, may unusually be problematic for a number of reasons including postural abnormalities, backache, psychological disturbance, and submammary intertrigo. The condition may occur at puberty (O'Hare and Frieden 2000) or during pregnancy (Parker et al 2017;Zhou et al 2017b;Shoma et al 2011). Its etiology is obscure, but a suggested cause is increased sensitivity of the breast tissue to normal levels of circulating hormones.…”
In this chapter, skin conditions of the breast are described including ones common and others involving the breast as an uncommon site and difficult for diagnosis. These conditions include developmental and physiological anomalies, inflammatory and vascular dermatoses, infections, congenital nevi, benign and malignant neoplasms, and related problems.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.